NO944025L - Forbedret fremstilling av rekombinant protein - Google Patents

Forbedret fremstilling av rekombinant protein

Info

Publication number
NO944025L
NO944025L NO944025A NO944025A NO944025L NO 944025 L NO944025 L NO 944025L NO 944025 A NO944025 A NO 944025A NO 944025 A NO944025 A NO 944025A NO 944025 L NO944025 L NO 944025L
Authority
NO
Norway
Prior art keywords
recombinant protein
improved production
production
improved
recombinant
Prior art date
Application number
NO944025A
Other languages
English (en)
Other versions
NO944025D0 (no
Inventor
Leif Kongerslev
John Pedersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO944025L publication Critical patent/NO944025L/no
Publication of NO944025D0 publication Critical patent/NO944025D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO944025A 1992-04-24 1994-10-21 Forbedret fremstilling av rekombinant protein NO944025D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK53792A DK53792D0 (da) 1992-04-24 1992-04-24 Fremgangsmaade til fremstilling af proteiner
PCT/DK1993/000138 WO1993022425A1 (en) 1992-04-24 1993-04-23 Improved recombinant protein production

Publications (2)

Publication Number Publication Date
NO944025L true NO944025L (no) 1994-10-21
NO944025D0 NO944025D0 (no) 1994-10-21

Family

ID=8094667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944025A NO944025D0 (no) 1992-04-24 1994-10-21 Forbedret fremstilling av rekombinant protein

Country Status (13)

Country Link
US (1) US5356798A (no)
EP (1) EP0640125A1 (no)
JP (1) JPH07505780A (no)
KR (1) KR950701380A (no)
AU (1) AU4260393A (no)
CA (1) CA2134198A1 (no)
CZ (1) CZ261394A3 (no)
DK (1) DK53792D0 (no)
FI (1) FI944997A0 (no)
HU (1) HUT68274A (no)
NO (1) NO944025D0 (no)
RU (1) RU94045945A (no)
WO (1) WO1993022425A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
IL154880A0 (en) * 2000-10-02 2003-10-31 Novo Nordisk As Method for the production of vitamin k-dependent proteins
US20040014657A1 (en) * 2001-11-05 2004-01-22 Jan Ohrstrom Use of blood coagulation factor XIII for treating haemophilia A
CA2460206C (en) 2001-10-02 2012-01-24 Novo Nordisk Health Care Ag Method for production of recombinant proteins in eukaryote cells
CA3188190A1 (en) * 2020-06-26 2021-12-30 Sunnybrook Research Institute Yolk extract supplements for culture media and related methods

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048289A1 (de) * 1980-12-20 1982-07-29 Hoechst Ag "verfahren zur zuechtung von insektenzellen"
JPH07106156B2 (ja) * 1983-10-28 1995-11-15 ジェネティックス、インスティチュ−ト ファクタ−▲ｖｉｉｉ▼および関連生産物の製造
ATE78871T1 (de) * 1984-01-12 1992-08-15 Chiron Corp Proteinzusammensetzung mit koagulations-wirkung und verfahren zu ihrer herstellung.
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
JPS6163283A (ja) * 1984-09-03 1986-04-01 Teijin Ltd ハイブリ−ド−マの培養方法
ES8801674A1 (es) * 1985-04-12 1988-02-16 Genetics Inst Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante.
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
WO1987004187A1 (en) * 1986-01-03 1987-07-16 Genetics Institute, Inc. METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS
FI98829C (fi) * 1986-01-27 1997-08-25 Chiron Corp Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta
US5451521A (en) * 1986-05-29 1995-09-19 Genetics Institute, Inc. Procoagulant proteins
EP0251843A1 (fr) * 1986-06-06 1988-01-07 Transgene S.A. Procédé de préparation de facteur VIII à partir de cellules de mammifères
EP0254076B1 (en) * 1986-07-11 1991-05-08 Miles Inc. Improved recombinant protein production
NO872932L (no) * 1986-07-18 1988-01-19 Gist Brocades Nv Fremgangsmaate for fremstilling av proteiner med faktorviiiaktivitet ved hjelp av mikrobielle vertsceller, eksprimeringsvektorer, vertsceller, antibiotika.
IL84168A0 (en) * 1986-10-15 1988-03-31 Rorer Int Overseas Human factor viii-c analogs,process for the preparation thereof and pharmaceutical compositions containing the same
US4980456A (en) * 1987-04-06 1990-12-25 Scripps Clinic And Research Foundation Recombinant factor VIIIC derived fragments
EP0294910B1 (en) * 1987-06-12 1996-09-11 Immuno Ag Novel proteins with factor VIII activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them
FR2619314B1 (fr) * 1987-08-11 1990-06-15 Transgene Sa Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant
EP0500734B1 (en) * 1989-11-17 1998-02-11 Novo Nordisk A/S Protein complexes having factor viii:c activity and production thereof
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.

Also Published As

Publication number Publication date
DK53792D0 (da) 1992-04-24
HUT68274A (en) 1995-06-28
FI944997A (fi) 1994-10-24
CA2134198A1 (en) 1993-11-11
EP0640125A1 (en) 1995-03-01
CZ261394A3 (en) 1995-02-15
JPH07505780A (ja) 1995-06-29
AU4260393A (en) 1993-11-29
NO944025D0 (no) 1994-10-21
HU9403070D0 (en) 1994-12-28
FI944997A0 (fi) 1994-10-24
KR950701380A (ko) 1995-03-23
US5356798A (en) 1994-10-18
RU94045945A (ru) 1997-03-27
WO1993022425A1 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
DK91192D0 (da) Protein
DE69323431D1 (de) Herstellung von feststoffmaterialien
NO963818D0 (no) Forhöyet sekresjon av polypeptider
DE69220382D1 (de) Verwendung von Peptidderivaten
NO960217D0 (no) Stabilisering av aerosoliserte proteiner
KR950702242A (ko) 사포린 함유 단백질의 재조합 생산방법(Recombinant production of saporin-containing proteins)
DK132892D0 (da) Proteiner
FI921059A0 (fi) Menetelmä hyötyproteiinien erittämiseksi hiivoista
FI941749A (fi) Rekombinantti-Borrelia -proteiinien valmistus
DE59405004D1 (de) Herstellung von 2-H-Heptafluorpropan
NO944025L (no) Forbedret fremstilling av rekombinant protein
KR950701894A (ko) 하이드로 플루오로 알칸 제조 방법(production of hydrofluoroalkanes)
DK75393D0 (da) Production of protein
GB9714680D0 (en) Recombinant production of proteins
DE69213637D1 (de) Herstellung von 2-Hydroxymandelsäuren und 2-Hydroxybenzaldehyden
NO934602D0 (no) Fremgangsmaate for fremstilling av polypeptider
GB9104596D0 (en) Production of recombinant proteins
FI951212A (fi) beta-metyylikarbapeneemivälituotteiden valmistus
DE69324908D1 (de) Verbesserte herstellung von aluminiumoxid
AU5462694A (en) Improved recombinant production of proteins having factor viii:c activity
FI935609A0 (fi) Asymmetrisk hydrering av dihydrofuroimidazolderivat
KR930026760U (ko) Tvcr의 개선된 구성
BR9305739A (pt) Fabricaçao de supercondutores alongadas
DE69331579D1 (de) Herstellung von 2d-arrays
GB9714681D0 (en) Recombinant production of proteins